Choose ALUNBRIG® (brigatinib): Download Helpful Resources for Patients


Dosing Guide

Dosing guide download.
Helpful information on the one-tablet, once-daily recommended dosage, and modifications for adverse reactions

Patient Brochure

Patient-friendly information to help them understand their treatment with ALUNBRIG

Current Topics in ALK+ mNSCLC

Current Topics in ALK+ mNSCLC download.
Dr. Viola W. Zhu discusses first-line treatment of ALK+ mNSCLC

Access Guide

Access guide download.
At-a-glance distribution details and supply information as well as ordering options

Video Resources

Talking ALK-Positive Opinions

Dr. Viola W. Zhu provides her perspective on treating patients with ALK+ mNSCLC in the front line and reviews the first-line clinical data for ALUNBRIG.

Exploring Key Efficacy, Safety, and Patient Data

Dr. Alex Spira, Director of the Virginia Cancer Specialists Research Institute, discusses ALUNBRIG for the treatment of adult patients with ALK+ mNSCLC.

Connect with our team

" "

Learn more about ALUNBRIG for first-line patients with ALK+ mNSCLC from an ALUNBRIG representative.


Discover whether ALUNBRIG is right for your patient with a 1-month free trial